Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
Mini sinus implant from Intersect gains FDA approval
The FDA has granted Intersect ENT approval for its Propel mini implant, a second-generation, smaller version of its steroid-eluting device designed to treat patients with chronic sinusitis. The company plans a limited U.S. launch of the device this month and a nationwide release next year.
Or we can send an email on your behalf